Genetic Analysis AS
ASActiveOrg 993373575Ulvenveien 80B, 0581 OsloEngineering activities and related technical consultancy· NACE 7112Est. 2008 · 18 years old16 employeeshttps://www.genetic-analysis.com
Loading company…
Overview
Genetic Analysis AS is a Norwegian AS based in Oslo, operating in the Engineering activities and related technical consultancy sector. Incorporated in 2008, the company has 16 employees and reported revenue of NOK 21.2m in its latest annual filing.
Revenue 2025
21.2M NOK
+2% vs 2024
EBITDA margin
−28.8 %
+32% vs 2024
Net profit 2025
-11.4M NOK
+23% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
51.6 %
AverageAround the average of companies in the same industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
1.6×
AverageAround the average of companies in the same industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
-21.8 %
Very weakAmong the 20% lowest rated companies in the industry
20212025
EBITDA — year on year
NOK millionsKey figures
Annual report 2025| Revenue | 21.2M NOK | +2% |
| EBITDA | -6.1M NOK | +32% |
| Net profit | -11.4M NOK | +23% |
| Total assets | 52.4M NOK | +24% |
| Equity | 27.1M NOK | +20% |
| Employees | 16 | — |
Company information
Legal name
GENETIC ANALYSIS AS
Org number
993373575
Legal form
Aksjeselskap
NACE code
Founded
15 September 2008 · 18 years
Share capital
NOK 41,452,224
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikle og selge teknologi for analyser av komplekse genetiske systemer.
(no translation available)
Contact
Address
Ulvenveien 80B, 0581 Oslo
Phone
+47 48 32 16 10
Email
info@genetic-analysis.com
Website
https://www.genetic-analysis.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Genetic Analysis AS reported revenue of NOK 21.2m, an increase of 2% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of NOK 11.4m, and the EBITDA margin stood at -28.8%.
At the end of 2025, equity financed 51.6% of the balance sheet, and current assets covered short-term debt 1.6 times.
Financials
Revenue
NOK millionsEBITDA
NOK millionsIncome statement
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 21,172 | 20,684 | 23,164 | 20,747 | 13,379 |
| Staff expenses | -16,056 | -19,268 | -23,559 | -25,196 | -22,835 |
| EBITDA | -6,091 | -8,974 | -18,259 | -23,350 | -24,340 |
| Depreciation & amort. | -5,173 | -5,242 | -5,579 | -4,834 | -4,531 |
| EBIT | -11,264 | -14,216 | -23,837 | -28,184 | -28,871 |
| Net financials | -149 | -553 | 19 | -90 | -134 |
| Profit before tax | -11,413 | -14,769 | -23,818 | -28,274 | -29,005 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -11,413 | -14,769 | -23,818 | -28,274 | -29,005 |
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
Balance sheet
NOK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 52,446 | 42,377 | 53,490 | 64,425 | 83,490 |
| Equity | 27,079 | 22,494 | 31,998 | 44,140 | 72,090 |
| Long-term debt | 0 | 16,084 | 5,448 | 7,338 | 1,432 |
| Short-term debt | 18,966 | 11,842 | 16,045 | 12,946 | 9,968 |
| Total debt | 25,367 | 19,884 | 21,492 | 20,284 | 11,400 |
Financial ratios
5-year trendEBITDA margin
-28.8 %
20212025
Equity ratio
51.6 %
AverageAround the average of companies in the same industry
20212025
Return on equity
-42.1 %
Very weakAmong the 20% lowest rated companies in the industry
20212025
Net profit margin
-53.9 %
Very weakAmong the 20% lowest rated companies in the industry
20212025
Asset turnover
0.40×
AverageAround the average of companies in the same industry
20212025
Debt / equity
0.94×
AverageAround the average of companies in the same industry
20212025
Sector performance
28 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginVery weak
Among the 20% lowest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginVery weak
Among the 20% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginVery weak
Among the 20% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Very weak
Among the 20% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very weak
Among the 20% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioWeak
Among the 40% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioAverage
Around the average of companies in the same industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioAverage
Around the average of companies in the same industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioStrong
Among the 40% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityAverage
Around the average of companies in the same industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalWeak
Among the 30% lowest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioWeak
Among the 30% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioAverage
Around the average of companies in the same industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioAverage
Around the average of companies in the same industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityAverage
Around the average of companies in the same industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityWeak
Among the 40% lowest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery weak
Among the 20% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtWeak
Among the 30% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 20% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtWeak
Among the 30% lowest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery weak
Among the 20% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverAverage
Around the average of companies in the same industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverWeak
Among the 40% lowest rated companies in the industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalWeak
Among the 30% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityStrong
Among the 30% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtWeak
Among the 30% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RH Chief Executive Officer | Chief Executive Officer | 2015 |
Former (1)
GM Deputy Member | Deputy Member | 2021 – 2021 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
TH Board of Directors | Board of Directors | 2024 |
AC Board of Directors | Board of Directors | 2021 |
RS Board of Directors | Board of Directors | 2021 |
RB Board of Directors | Board of Directors | 2024 |
MJ Chairman | Chairman | 2025 |
PO Board of Directors | Board of Directors | 2025 |
Former (7)
JL Chairman | Chairman | 2024 – 2025 |
SS Board of Directors | Board of Directors | 2021 – 2023 |
MS Board of Directors | Board of Directors | 2024 – 2025 |
AK Board of Directors | Board of Directors | 2021 – 2022 |
PN Chairman | Chairman | 2022 – 2024 |
KM Chairman | Chairman | 2021 – 2022 |
AG Board of Directors | Board of Directors | 2022 – 2024 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 23.97% | 23.97% | 2025 | |
| Company | 9.59% | 9.59% | 2025 | |
| Company | 6.17% | 6.17% | 2025 | |
| Company | 4.89% | 4.89% | 2025 | |
| Company | 3.98% | 3.98% | 2025 | |
| Company | 3.84% | 3.84% | 2025 | |
| Company | 3.29% | 3.29% | 2025 | |
| Individual | 3.19% | 3.19% | 2025 | |
| Company | 2.81% | 2.81% | 2025 | |
| Company | 2.79% | 2.79% | 2025 | |
| Individual | 2.65% | 2.65% | 2025 | |
| Individual | 2.46% | 2.46% | 2025 | |
| Company | 2.12% | 2.12% | 2025 | |
| Company | 2.09% | 2.09% | 2025 | |
| Company | 2.06% | 2.06% | 2025 | |
| Company | 1.53% | 1.53% | 2025 | |
| Company | 1.27% | 1.27% | 2025 | |
| Individual | 1.16% | 1.16% | 2025 | |
| Company | 1.01% | 1.01% | 2025 | |
| Company | 0.72% | 0.72% | 2025 | |
| Company | 0.64% | 0.64% | 2025 | |
| Company | 0.61% | 0.61% | 2025 | |
| Individual | 0.58% | 0.58% | 2025 | |
| Company | 0.54% | 0.54% | 2025 | |
| Company | 0.54% | 0.54% | 2025 | |
| Company | 0.37% | 0.37% | 2025 | |
| Individual | 0.24% | 0.24% | 2025 | |
| Company | 0.13% | 0.13% | 2025 | |
| Individual | 0.04% | 0.04% | 2025 | |
| Company | 1.44% | 1.44% | 2020 | |
Avanza Bank Ab | Company | 10.25% | 10.25% | 2024 |
Nordea Bank Abp | Company | 0.22% | 0.22% | 2024 |
Svenska Handelsbanken Ab | Company | 0.64% | 0.64% | 2024 |
| Company | 4.76% | 4.76% | 2020 | |
| Company | 1.1% | 1.1% | 2023 | |
| Company | 2.37% | 2.37% | 2020 | |
| Company | 8.32% | 8.32% | 2020 | |
Skandinaviska Enskilda Banken Ab | Company | 2.88% | 2.88% | 2024 |
Citibank, N.A. | Company | 22.49% | 22.49% | 2024 |
Nordnet Bank Ab | Company | 5.1% | 5.1% | 2024 |
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Related companies
Company hierarchy
Avanza Bank Ab9.5869%Citibank, N.A.23.9727%Muen Invest As6.1668%Ochrino As4.89%Lucellum As3.98%Nordnet Bank Ab3.84%S. Munkhaugen As3.29%Ljm As2.81%Kagge As2.79%Invitrodia As2.12%Molver As2.09%Nordea Bank Abp2.06%Stella Invest As1.53%Swedbank Ab1.01%Jama Holding As0.72%Arvo Invest As0.64%Lemica As0.54%Frostad Invest As0.54%Sagahill As0.37%Betulum As0.13%Svenska Handelsbanken Ab0.64%Rolfs Holding As1.1%Norda Asa2.37%Skandinaviska Enskilda Banken Ab2.88%
Genetic Analysis AS (this company)Prokarimi AS14.6512% ownedBoard network connections
Board members of Genetic Analysis AS also hold positions in 105 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thorvald Helmen Steen | Board of Directors | 66 companiesMany roles |
| Rune Sørum | Board of Directors | 12 companiesMany roles |
| Kathryn Moore Baker | Chairman | 9 companiesMany roles |
| Morten Jurs | Chairman | 6 companiesMany roles |
| Ronny Hermansen | Chief Executive Officer | 4 companies |
| Jethro Lee Holter | Chairman | 3 companies |
| Marie Skarbøvik Buchmann | Board of Directors | 3 companies |
| Anne Camilla Huse Bondesson | Board of Directors | 2 companies |
Frequently asked questions
What is the Org number of Genetic Analysis AS?
Genetic Analysis AS is registered with Brønnøysundsregistrene under Org 993373575.
What is the revenue of Genetic Analysis AS?
Genetic Analysis AS reported revenue of NOK 21.2m in 2025.
How many employees does Genetic Analysis AS have?
Genetic Analysis AS employs 16 people as of the latest annual report.
Who is the CEO of Genetic Analysis AS?
Ronny Hermansen is the CEO of Genetic Analysis AS, in role since 2015.
Who is the chairman of Genetic Analysis AS?
Morten Jurs chairs the board of Genetic Analysis AS, in role since 2025.
Where is Genetic Analysis AS headquartered?
Genetic Analysis AS's registered address is Ulvenveien 80B.